Dermapharm Holding SE

    Dermapharm Holding SE

    FFRA:52D0
    0.21
    EUR
    -0.01
    (-4.82%)
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    - -
    0.05
    0.06
    0.08
    0.07
    0.06
    Basic EPS, GAAP
    -0.15
    -0.28
    -0.04
    - -
    -0.08
    -0.06
    Free Cash Flow per Basic Share
    -0.16
    -0.16
    -0.04
    - -
    -0.03
    -0.02
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    0.41
    0.85
    0.16
    0.16
    0.09
    0.08
    Tangible Book Value per Share
    0.34
    -0.03
    0.05
    0.06
    0.02
    0.01
    Basic Weighted Avg Shares
    34
    128
    438
    649
    662
    664
    Sales/Revenue/Turnover
    - -
    6
    28
    55
    46
    37
    Operating Margin (%)
    - -
    -627.43
    -60.53
    -8.75
    -53.83
    -74.74
    Depreciation Expense
    - -
    5
    11
    9
    8
    8
    Net Income, GAAP
    -5
    -36
    -17
    -1
    -51
    -42
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    -549.1
    -61.88
    -2.26
    -111.03
    -113.23
    Working Capital
    21
    12
    26
    34
    13
    8
    LT Debt
    - -
    - -
    - -
    - -
    2
    1
    Total Equity
    25
    165
    104
    102
    60
    53
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    -37.43
    -13.01
    -1.2
    -62.99
    -57.63

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'26
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    2
    1
    1
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    665
    665
    666
    Market Capitalization
    227
    196
    208

    Working Capital

    CAD

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'26
    Total Current Assets
    2,350
    1,624
    1,172
    Cash, Cash Equivalents & STI
    32
    29
    27
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    10
    7
    3
    Total Current Liabilities
    2,324
    1,610
    1,163
    Payables & Accruals
    11
    11
    11
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    - -
    -41.82%
    Free Cash Flow
    - -
    - -
    671.16%
    Net Income, GAAP
    - -
    - -
    4,012.11%
    Sales/Revenue/Turnover
    - -
    - -
    -16.29%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    19
    12
    7
    20
    55
    2025
    16
    10
    11
    9
    46
    2026
    7
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    0.01
    - -
    -0.01
    - -
    - -
    2025
    -0.02
    -0.01
    -0.02
    - -
    -0.08
    2026
    -0.01
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business